Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
This report aims to provide a comprehensive presentation of the global market for Gene-based Advanced Therapy Medicinal, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene-based Advanced Therapy Medicinal. This report contains market size and forecasts of Gene-based Advanced Therapy Medicinal in global, including the following market information:
Global Gene-based Advanced Therapy Medicinal Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Gene-based Advanced Therapy Medicinal market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Viral Gene Delivery System Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gene-based Advanced Therapy Medicinal include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Sunway Biotech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene-based Advanced Therapy Medicinal companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene-based Advanced Therapy Medicinal Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Gene-based Advanced Therapy Medicinal Market Segment Percentages, by Type, 2022 (%)
Viral Gene Delivery System
Non-viral Gene Delivery System
Global Gene-based Advanced Therapy Medicinal Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Gene-based Advanced Therapy Medicinal Market Segment Percentages, by Application, 2022 (%)
Neurological Diseases
Cancer
Other
Global Gene-based Advanced Therapy Medicinal Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Gene-based Advanced Therapy Medicinal Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene-based Advanced Therapy Medicinal revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene-based Advanced Therapy Medicinal revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene-based Advanced Therapy Medicinal, market overview.
Chapter 2: Global Gene-based Advanced Therapy Medicinal market size in revenue.
Chapter 3: Detailed analysis of Gene-based Advanced Therapy Medicinal company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene-based Advanced Therapy Medicinal in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gene-based Advanced Therapy Medicinal Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene-based Advanced Therapy Medicinal Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene-based Advanced Therapy Medicinal Overall Market Size
2.1 Global Gene-based Advanced Therapy Medicinal Market Size: 2022 VS 2029
2.2 Global Gene-based Advanced Therapy Medicinal Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene-based Advanced Therapy Medicinal Players in Global Market
3.2 Top Global Gene-based Advanced Therapy Medicinal Companies Ranked by Revenue
3.3 Global Gene-based Advanced Therapy Medicinal Revenue by Companies
3.4 Top 3 and Top 5 Gene-based Advanced Therapy Medicinal Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gene-based Advanced Therapy Medicinal Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene-based Advanced Therapy Medicinal Players in Global Market
3.6.1 List of Global Tier 1 Gene-based Advanced Therapy Medicinal Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene-based Advanced Therapy Medicinal Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene-based Advanced Therapy Medicinal Market Size Markets, 2022 & 2029
4.1.2 Viral Gene Delivery System
4.1.3 Non-viral Gene Delivery System
4.2 By Type - Global Gene-based Advanced Therapy Medicinal Revenue & Forecasts
4.2.1 By Type - Global Gene-based Advanced Therapy Medicinal Revenue, 2018-2023
4.2.2 By Type - Global Gene-based Advanced Therapy Medicinal Revenue, 2024-2029
4.2.3 By Type - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene-based Advanced Therapy Medicinal Market Size, 2022 & 2029
5.1.2 Neurological Diseases
5.1.3 Cancer
5.1.4 Other
5.2 By Application - Global Gene-based Advanced Therapy Medicinal Revenue & Forecasts
5.2.1 By Application - Global Gene-based Advanced Therapy Medicinal Revenue, 2018-2023
5.2.2 By Application - Global Gene-based Advanced Therapy Medicinal Revenue, 2024-2029
5.2.3 By Application - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Gene-based Advanced Therapy Medicinal Market Size, 2022 & 2029
6.2 By Region - Global Gene-based Advanced Therapy Medicinal Revenue & Forecasts
6.2.1 By Region - Global Gene-based Advanced Therapy Medicinal Revenue, 2018-2023
6.2.2 By Region - Global Gene-based Advanced Therapy Medicinal Revenue, 2024-2029
6.2.3 By Region - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Gene-based Advanced Therapy Medicinal Revenue, 2018-2029
6.3.2 US Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.3.3 Canada Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.3.4 Mexico Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Gene-based Advanced Therapy Medicinal Revenue, 2018-2029
6.4.2 Germany Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.4.3 France Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.4.4 U.K. Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.4.5 Italy Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.4.6 Russia Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.4.7 Nordic Countries Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.4.8 Benelux Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Gene-based Advanced Therapy Medicinal Revenue, 2018-2029
6.5.2 China Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.5.3 Japan Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.5.4 South Korea Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.5.5 Southeast Asia Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.5.6 India Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Gene-based Advanced Therapy Medicinal Revenue, 2018-2029
6.6.2 Brazil Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.6.3 Argentina Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue, 2018-2029
6.7.2 Turkey Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.7.3 Israel Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.7.4 Saudi Arabia Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
6.7.5 UAE Gene-based Advanced Therapy Medicinal Market Size, 2018-2029
7 Gene-based Advanced Therapy Medicinal Companies Profiles
7.1 Biogen
7.1.1 Biogen Company Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Gene-based Advanced Therapy Medicinal Major Product Offerings
7.1.4 Biogen Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.1.5 Biogen Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Gene-based Advanced Therapy Medicinal Major Product Offerings
7.2.4 Novartis Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Gilead Sciences
7.3.1 Gilead Sciences Company Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Gene-based Advanced Therapy Medicinal Major Product Offerings
7.3.4 Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.3.5 Gilead Sciences Key News & Latest Developments
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Company Summary
7.4.2 Sarepta Therapeutics Business Overview
7.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Major Product Offerings
7.4.4 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.4.5 Sarepta Therapeutics Key News & Latest Developments
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Company Summary
7.5.2 Alnylam Pharmaceuticals Business Overview
7.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Major Product Offerings
7.5.4 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.5.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Gene-based Advanced Therapy Medicinal Major Product Offerings
7.6.4 Amgen Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Company Summary
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Gene-based Advanced Therapy Medicinal Major Product Offerings
7.7.4 Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.7.5 Spark Therapeutics Key News & Latest Developments
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Company Summary
7.8.2 Akcea Therapeutics Business Overview
7.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Major Product Offerings
7.8.4 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.8.5 Akcea Therapeutics Key News & Latest Developments
7.9 Sunway Biotech
7.9.1 Sunway Biotech Company Summary
7.9.2 Sunway Biotech Business Overview
7.9.3 Sunway Biotech Gene-based Advanced Therapy Medicinal Major Product Offerings
7.9.4 Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.9.5 Sunway Biotech Key News & Latest Developments
7.10 SIBIONO
7.10.1 SIBIONO Company Summary
7.10.2 SIBIONO Business Overview
7.10.3 SIBIONO Gene-based Advanced Therapy Medicinal Major Product Offerings
7.10.4 SIBIONO Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.10.5 SIBIONO Key News & Latest Developments
7.11 AnGes
7.11.1 AnGes Company Summary
7.11.2 AnGes Business Overview
7.11.3 AnGes Gene-based Advanced Therapy Medicinal Major Product Offerings
7.11.4 AnGes Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.11.5 AnGes Key News & Latest Developments
7.12 Orchard Therapeutics
7.12.1 Orchard Therapeutics Company Summary
7.12.2 Orchard Therapeutics Business Overview
7.12.3 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Major Product Offerings
7.12.4 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.12.5 Orchard Therapeutics Key News & Latest Developments
7.13 Human Stem Cells Institute
7.13.1 Human Stem Cells Institute Company Summary
7.13.2 Human Stem Cells Institute Business Overview
7.13.3 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Major Product Offerings
7.13.4 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.13.5 Human Stem Cells Institute Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gene-based Advanced Therapy Medicinal Market Opportunities & Trends in Global Market
Table 2. Gene-based Advanced Therapy Medicinal Market Drivers in Global Market
Table 3. Gene-based Advanced Therapy Medicinal Market Restraints in Global Market
Table 4. Key Players of Gene-based Advanced Therapy Medicinal in Global Market
Table 5. Top Gene-based Advanced Therapy Medicinal Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gene-based Advanced Therapy Medicinal Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gene-based Advanced Therapy Medicinal Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gene-based Advanced Therapy Medicinal Product Type
Table 9. List of Global Tier 1 Gene-based Advanced Therapy Medicinal Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene-based Advanced Therapy Medicinal Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Gene-based Advanced Therapy Medicinal Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gene-based Advanced Therapy Medicinal Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Gene-based Advanced Therapy Medicinal Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gene-based Advanced Therapy Medicinal Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2024-2029
Table 30. Biogen Company Summary
Table 31. Biogen Gene-based Advanced Therapy Medicinal Product Offerings
Table 32. Biogen Gene-based Advanced Therapy Medicinal Revenue (US$, Mn) & (2018-2023)
Table 33. Biogen Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Gene-based Advanced Therapy Medicinal Product Offerings
Table 36. Novartis Gene-based Advanced Therapy Medicinal Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Gilead Sciences Company Summary
Table 39. Gilead Sciences Gene-based Advanced Therapy Medicinal Product Offerings
Table 40. Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue (US$, Mn) & (2018-2023)
Table 41. Gilead Sciences Key News & Latest Developments
Table 42. Sarepta Therapeutics Company Summary
Table 43. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Product Offerings
Table 44. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue (US$, Mn) & (2018-2023)
Table 45. Sarepta Therapeutics Key News & Latest Developments
Table 46. Alnylam Pharmaceuticals Company Summary
Table 47. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Product Offerings
Table 48. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue (US$, Mn) & (2018-2023)
Table 49. Alnylam Pharmaceuticals Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Gene-based Advanced Therapy Medicinal Product Offerings
Table 52. Amgen Gene-based Advanced Therapy Medicinal Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Spark Therapeutics Company Summary
Table 55. Spark Therapeutics Gene-based Advanced Therapy Medicinal Product Offerings
Table 56. Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue (US$, Mn) & (2018-2023)
Table 57. Spark Therapeutics Key News & Latest Developments
Table 58. Akcea Therapeutics Company Summary
Table 59. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Product Offerings
Table 60. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue (US$, Mn) & (2018-2023)
Table 61. Akcea Therapeutics Key News & Latest Developments
Table 62. Sunway Biotech Company Summary
Table 63. Sunway Biotech Gene-based Advanced Therapy Medicinal Product Offerings
Table 64. Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue (US$, Mn) & (2018-2023)
Table 65. Sunway Biotech Key News & Latest Developments
Table 66. SIBIONO Company Summary
Table 67. SIBIONO Gene-based Advanced Therapy Medicinal Product Offerings
Table 68. SIBIONO Gene-based Advanced Therapy Medicinal Revenue (US$, Mn) & (2018-2023)
Table 69. SIBIONO Key News & Latest Developments
Table 70. AnGes Company Summary
Table 71. AnGes Gene-based Advanced Therapy Medicinal Product Offerings
Table 72. AnGes Gene-based Advanced Therapy Medicinal Revenue (US$, Mn) & (2018-2023)
Table 73. AnGes Key News & Latest Developments
Table 74. Orchard Therapeutics Company Summary
Table 75. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Product Offerings
Table 76. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue (US$, Mn) & (2018-2023)
Table 77. Orchard Therapeutics Key News & Latest Developments
Table 78. Human Stem Cells Institute Company Summary
Table 79. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Product Offerings
Table 80. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue (US$, Mn) & (2018-2023)
Table 81. Human Stem Cells Institute Key News & Latest Developments
List of Figures
Figure 1. Gene-based Advanced Therapy Medicinal Segment by Type in 2022
Figure 2. Gene-based Advanced Therapy Medicinal Segment by Application in 2022
Figure 3. Global Gene-based Advanced Therapy Medicinal Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gene-based Advanced Therapy Medicinal Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gene-based Advanced Therapy Medicinal Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene-based Advanced Therapy Medicinal Revenue in 2022
Figure 8. By Type - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2029
Figure 9. By Application - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2029
Figure 10. By Type - Global Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2029
Figure 12. By Application - Global Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2029
Figure 14. By Region - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2029
Figure 15. By Country - North America Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2029
Figure 16. US Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2029
Figure 20. Germany Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 21. France Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2029
Figure 28. China Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 32. India Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2029
Figure 34. Brazil Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2029
Figure 37. Turkey Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2029
Figure 41. Biogen Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. SIBIONO Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. AnGes Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
